Research & development increased 143.0%
Research & development changed +143.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development changed +143.0% from the comparable as-filed period.
Current liabilities changed +496.9% from the comparable as-filed period.
Current ratio changed -82.8% from the comparable as-filed period.
Working capital / assets changed -17270 basis points from the comparable as-filed period.
Stock-based compensation changed +47.1% from the comparable as-filed period.
Total assets changed -4.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed -17819.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Current assets changed +2.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.